One-Year Results of ZBIS Iliac Branch Device With an Off-Label Connection Limb

dc.contributor.authorTorrealba, Jose
dc.contributor.authorPanuccio, Giuseppe
dc.contributor.authorRohlffs, Fiona
dc.contributor.authorGandet, Thomas
dc.contributor.authorGronert, Catharina
dc.contributor.authorHeidemann, Franziska
dc.contributor.authorTsilimparis, Nikolaos
dc.contributor.authorKoelbel, Tilo
dc.date.accessioned2025-01-20T22:01:37Z
dc.date.available2025-01-20T22:01:37Z
dc.date.issued2022
dc.description.abstractPurpose: The purpose of this article is to study 1-year results of Zenith branch iliac endovascular graft (ZBIS) with the off-label use of a 13 mm spiral Z limb to connect to the aortic main body. Materials and Methods: A retrospective review from 2015 to 2019 of all iliac branch devices (IBDs) was performed at 1 institution that were connected to an aortic main body with a 13 mm spiral Z limb and had at least 1-year follow-up with computed tomography (CT). Primary endpoints are freedom from ZBIS separation from the connection limb, endoleak (EL), or reintervention at 1 year. Secondary endpoints are primary and secondary ZBIS patency, presence of any EL, and aortic reinterventions. Results: Of 149 IBDs implanted in this period, 45 ZBIS in 35 patients were connected with a 13 mm limb and had a 1-year CT; 97% of patients had common iliac artery (CIA) aneurysms, 7% of patients had hypogastric artery (HA) aneurysms, and 30% of patients had bilateral ZBIS implantation. Technical success was 98%. In 84% of cases, the Advanta V12 was used as the HA mating stent; 56% of patients had an EL, mostly type II, which resolved spontaneously in 70% at 1 year, and 9% of ZBIS required reinterventions at 1 year (2 for thrombosis, 2 for type Ic EL from HA mating stent). One-year ZBIS primary patency and secondary patency were 96% and 100%, respectively. No EL was noted to be related to the 13 mm connection limb. No migration or separation of the devices occurred. Conclusions: The use of 13 mm spiral Z limb to connect a ZBIS with the main body in our series yields a high technical success rate and good 12-month outcomes without device separation or migration.
dc.fuente.origenWOS
dc.identifier.doi10.1177/15266028211054760
dc.identifier.eissn1545-1550
dc.identifier.issn1526-6028
dc.identifier.urihttps://doi.org/10.1177/15266028211054760
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/93859
dc.identifier.wosidWOS:000713599300001
dc.issue.numero3
dc.language.isoen
dc.pagina.final408
dc.pagina.inicio402
dc.revistaJournal of endovascular therapy
dc.rightsacceso restringido
dc.subjectiliac branch device
dc.subjectaortoiliac aneurysm
dc.subjectcommon iliac artery aneurysm
dc.subjecthypogastric artery
dc.subjectbranched stent graft
dc.subjectiliac artery
dc.subjectinternal iliac artery
dc.subjectendoleak
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleOne-Year Results of ZBIS Iliac Branch Device With an Off-Label Connection Limb
dc.typeartículo
dc.volumen29
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files